Surgery and Actinomycin Improve Survival in Malignant Rhabdoid Tumor
Figure 3
Kaplan-Meier survival of patients diagnosed with extrarenal extra-CNS malignant rhabdoid tumor with four-year survival comparing patients less than two years old versus older than two at diagnosis was 11% versus 35%, respectively ().
